1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSPORE in Pancreatic Cancer Career Enhancement Program Awards (CEP) is sponsored by National Cancer Institute (NCI), National Institutes of Health (NIH). This program focuses on recruiting and supporting new independent investigators in translational pancreatic cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Career Enhancement Program Parent Project Number5P50CA272213-03 Contact PI/Project Leader GILLANDERS, WILLIAM E. The SPORE in Pancreatic Cancer Career Enhancement Program (CEP) aims to recruit and support new independent investigators in translational pancreatic cancer research.
Along with the Developmental Research Program (DRP), the CEP will provide financial support, didactic training, and mentored research opportunities to prepare investigators for independent careers in translational pancreatic cancer research. We propose the following specific aims: Specific Aim 1: Recruit and support new investigators in translational pancreatic cancer research.
In addition to the NCI funds, a total of $323,000 in institutional support is committed in support of the CEP program. CEP awards will provide $75K per year for 2 years. Awardees will be junior faculty beginning their research careers or transitioning into translational pancreatic cancer research.
Funded initiatives are expected to have a major translational component and focus on pancreatic cancer etiology, prevention, diagnosis, early detection, treatment, or population science. Specific Aim 2: Train and mentor junior faculty in translational pancreatic cancer research.
All CEP awardees will be mentored by both a senior basic science and clinical mentor and will craft an individualized career development plan that includes didactic coursework, patient care, and career skills training. We will leverage institutional educational opportunities to include courses in clinical trial design, biostatistics, and ethics.
The SPORE CEP Steering Committee will track and evaluate CEP awardees’ research and career development. Specific Aim 3: Foster inter-SPORE collaborations.
An educational exchange with our peer Pancreatic or GI SPORE institutions (University of Nebraska, Mayo Clinic, John Hopkins, University of North Carolina, University of California System) allows CEP awardees to present their research, receive expert feedback, meet peer SPORE leadership, and develop collaborations.
Content experts from peer SPORE institutions will perform critical reviews and provide formal feedback for CEP awardees’ extramural grant applications. Relevance: These aims will support research for the next generation of PDAC researchers and projects to improve our understanding of pancreatic cancer biology and develop new therapeutic approaches.
Public Health Relevance Statement Continued improvement in outcomes for pancreatic cancer patients requires recruitment and support of new independent investigators in the field of translational pancreatic cancer research. To accomplish this objective, the CEP will provide financial support, didactic training, and mentored research opportunities to promote multidisciplinary translational research.
Cancer Clinical Research Clinical Trials and Supportive Activities Digestive Diseases Pancreatic Cancer Prevention Rare Diseases Translational Research Applications Grants Award Basic Science Biometry California Cancer Biology Cancer Etiology Clinic Clinical Clinical Trials Design Collaborations Development Development Plans Diagnosis Early Diagnosis Education Ethics Extramural Activities Faculty Feedback Financial Support Fostering Funding Image Institution Leadership Malignant Neoplasms Malignant neoplasm of pancreas Mentors Nebraska North Carolina Outcome Pancreas Patient Care Population Sciences Prevention Professional Competence Research Research Personnel Research Support System Training Translational Research Universities Washington anti-cancer research career career development improved multidisciplinary next generation novel strategies novel therapeutic intervention pancreatic cancer patients peer programs recruit research and development skills training success Domestic Higher Education Administering Institutes or Centers National Cancer Institute Assistance Listing Number Project Funding Information for 2025 NIH Categorical SpendingClick here for more information on NIH Categorical Spending No Sub Projects information available for 5P50CA272213-03 9848 Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding.
This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50CA272213-03 9848 No Patents information available for 5P50CA272213-03 9848 The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50CA272213-03 9848 No Clinical Studies information available for 5P50CA272213-03 9848 No news release information available for 5P50CA272213-03 9848 No Historical information available for 5P50CA272213-03 9848 No Similar Projects information available for 5P50CA272213-03 9848 ## Select options for export:
According to the current listing, eligibility includes: New independent investigators in the field of translational pancreatic cancer research. View the full RFA for specific eligibility requirements. Confirm the full requirements in the official notice before applying.
SPORE in Pancreatic Cancer Career Enhancement Program Awards (CEP) is funded by National Cancer Institute (NCI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article